当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
Diovan tablets
儿科标签批准日期
2021/4/19 0:00:00
特定指示/秒
Hypertension in pediatric patients 1 year and older
标签更改摘要
- Expanded indication to include pediatric patients 1 – less than 6 years; previously approved down to 6 years.
- Use of Diovan is not recommended in children less than 1 year of age. It is not known whether post-natal use of valsartan, before maturation of renal function is complete, has a long-term deleterious effect on the kidney.
- Information on dosing, PK parameters, adverse reactions, and clinical trials.